Table 2.
Number | A | B | C | D | E | F | G | H | Total |
---|---|---|---|---|---|---|---|---|---|
1 [21] | 2 | 0 | 2 | 2 | 0 | 2 | 2 | 1 | 11 |
2 [20] | 2 | 2 | 2 | 2 | 0 | 2 | 2 | 1 | 13 |
3 [17] | 2 | 0 | 2 | 2 | 0 | 2 | 1 | 1 | 10 |
4 [18] | 2 | 0 | 2 | 2 | 0 | 2 | 2 | 0 | 10 |
5 [16] | 2 | 0 | 2 | 2 | 0 | 2 | 2 | 1 | 11 |
6 [19] | 2 | 0 | 2 | 2 | 0 | 2 | 2 | 1 | 11 |
7 [15] | 2 | 0 | 2 | 2 | 0 | 2 | 2 | 1 | 11 |
8 [14] | 2 | 2 | 2 | 2 | 0 | 2 | 2 | 0 | 12 |
9 [13] | 2 | 0 | 2 | 2 | 0 | 2 | 2 | 0 | 10 |
A: a clearly stated aim; B: inclusion of consecutive patients; C: prospective collection of data; D: endpoints appropriate to the aim of the study; E: unbiased assessment of the study endpoint; F: follow-up period appropriate to the aim of the study; G: loss to follow-up less than 5%; H: prospective calculation of the sample size.